Vectus Biosystems logo

VBS - Vectus Biosystems News Story

A$1.3 0.0  0.0%

Last Trade - 23/07/21

Sector
Healthcare
Size
Micro Cap
Market Cap £22.1m
Enterprise Value £21.8m
Revenue £54.3k
Position in Universe 1210th / 1940

BRIEF-Vectus Biosystems Says Approval Received For Phase I Trial In Australia

Thu 17th June, 2021 2:21am
June 17 (Reuters) - Vectus Biosystems Ltd  VBS.AX :
    * VECTUS BIOSYSTEMS LTD - APPROVAL RECEIVED FOR PHASE I
TRIAL IN
AUSTRALIA

Source text for Eikon:  ID:nASX49pDrp 
Further company coverage:  VBS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.